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Summary
Background We  investigated  a  consecutive  series  of
children  with  chronic  enterocolitis  and  regressive
developmental disorder.
Methods 12 children (mean age 6 years [range 3–10], 11
boys) were referred to a paediatric gastroenterology unit
with a history of normal development followed by loss of
acquired skills, including language, together with diarrhoea
and  abdominal  pain.  Children  underwent
gastroenterological,  neurological,  and  developmental
assessment  and  review  of  developmental  records.
Ileocolonoscopy and biopsy sampling, magnetic-resonance
imaging (MRI), electroencephalography (EEG), and lumbar
puncture were done under sedation. Barium follow-through
radiography  was  done  where  possible.  Biochemical,
haematological,  and  immunological  profiles  were
examined.
Findings Onset of behavioural symptoms was associated,
by  the  parents,  with  measles,  mumps,  and  rubella
vaccination  in  eight  of  the  12  children,  with  measles
infection in one child, and otitis media in another. All 12
children  had  intestinal  abnormalities,  ranging  from
lymphoid  nodular  hyperplasia  to  aphthoid  ulceration.
Histology showed patchy chronic inflammation in the colon
in  11  children  and  reactive  ileal  lymphoid  hyperplasia  in
seven, but no granulomas. Behavioural disorders included
autism (nine), disintegrative psychosis (one), and possible
postviral  or  vaccinal  encephalitis  (two).  There  were  no
focal  neurological  abnormalities  and  MRI  and  EEG  tests
were normal. Abnormal laboratory results were significantly
raised  urinary  methylmalonic  acid  compared  with  age-
matched  controls  (p=0·003),  low  haemoglobin  in  four
children, and a low serum IgA in four children.
Interpretation We  identified  associated  gastrointestinal
disease  and  developmental  regression  in  a  group  of
previously normal children, which was generally associated
in time with possible environmental triggers.
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Introduction
We saw several children who, after a period of apparent
normality, lost acquired skills, including communication.
They  all  had  gastrointestinal  symptoms,  including
abdominal  pain,  diarrhoea,  and  bloating  and,  in  some
cases, food intolerance. We describe the clinical findings,
and gastrointestinal features of these children.
Patients and methods
12  children,  consecutively  referred  to  the  department  of
paediatric  gastroenterology  with  a  history  of  a  pervasive
developmental disorder with loss of acquired skills and intestinal
symptoms  (diarrhoea,  abdominal  pain,  bloating  and  food
intolerance), were investigated. All children were admitted to the
ward for 1 week, accompanied by their parents.
Clinical investigations
We  took  histories,  including  details  of  immunisations  and
exposure to infectious diseases, and assessed the children. In 11
cases  the  history  was  obtained  by  the  senior  clinician  (JW-S).
Neurological  and  psychiatric  assessments  were  done  by
consultant staff (PH, MB) with HMS-4 criteria.
1 Developmental
histories included a review of prospective developmental records
from  parents,  health  visitors,  and  general  practitioners.  Four
children did not undergo psychiatric assessment in hospital; all
had been assessed professionally elsewhere, so these assessments
were used as the basis for their behavioural diagnosis.
After  bowel  preparation,  ileocolonoscopy  was  performed  by
SHM or MAT under sedation with midazolam and pethidine.
Paired frozen and formalin-fixed mucosal biopsy samples were
taken  from  the  terminal  ileum;  ascending,  transverse,
descending,  and  sigmoid  colons,  and  from  the  rectum.  The
procedure  was  recorded  by  video  or  still  images,  and  were
compared  with  images  of  the  previous  seven  consecutive
paediatric colonoscopies (four normal colonoscopies and three
on  children  with  ulcerative  colitis),  in  which  the  physician
reported  normal  appearances  in  the  terminal  ileum.  Barium
follow-through radiography was possible in some cases. 
Also  under  sedation,  cerebral  magnetic-resonance  imaging
(MRI),  electroencephalography  (EEG)  including  visual,  brain
stem auditory, and sensory evoked potentials (where compliance
made these possible), and lumbar puncture were done.
Laboratory investigations
Thyroid  function,  serum  long-chain  fatty  acids,  and
cerebrospinal-fluid  lactate  were  measured  to  exclude  known
causes  of  childhood  neurodegenerative  disease.  Urinary
methylmalonic acid was measured in random urine samples from
eight of the 12 children and 14 age-matched and sex-matched
normal  controls,  by  a  modification  of  a  technique  described
previously.
2 Chromatograms  were  scanned  digitally  on
computer, to analyse the methylmalonic-acid zones from cases
and  controls.  Urinary  methylmalonic-acid  concentrations  in
patients  and  controls  were  compared  by  a  two-sample  t test.
Urinary creatinine was estimated by routine spectrophotometric
assay.
Children  were  screened  for  antiendomyseal  antibodies  and
boys  were  screened  for  fragile-X  if  this  had  not  been  done
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before.  Stool  samples  were  cultured  for  Campylobacter spp,
Salmonella spp, and Shigella spp and assessed by microscopy for
ova and parasites. Sera were screened for antibodies to Yersinia
enterocolitica.
Histology
Formalin-fixed biopsy samples of ileum and colon were assessed
and  reported  by  a  pathologist  (SED).  Five  ileocolonic  biopsy
series  from  age-matched  and  site-matched  controls  whose
reports showed histologically normal mucosa were obtained for
comparison. All tissues were assessed by three other clinical and
experimental pathologists (APD, AA, AJW).
Ethical approval and consent
Investigations were approved by the Ethical Practices Committee
of  the  Royal  Free  Hospital  NHS Trust,  and  parents  gave
informed consent.
Results
Clinical details of the children are shown in tables 1 and
2.  None  had  neurological  abnormalities  on  clinical
examination; MRI scans, EEGs, and cerebrospinal-fluid
profiles  were  normal;  and  fragile  X  was  negative.
Prospective  developmental  records  showed  satisfactory
achievement of early milestones in all children. The only
girl  (child  number  eight)  was  noted  to  be  a  slow
developer  compared  with  her  older  sister.  She  was
subsequently found to have coarctation of the aorta. After
surgical repair of the aorta at the age of 14 months, she
progressed  rapidly,  and  learnt  to  talk.  Speech  was  lost
later. Child four was kept under review for the first year
of  life  because  of  wide  bridging  of  the  nose.  He  was
discharged from follow-up as developmentally normal at
age 1 year.
In  eight  children,  the  onset  of  behavioural  problems
had been linked, either by the parents or by the child’s
physician, with measles, mumps, and rubella vaccination.
Five had had an early adverse reaction to immunisation
(rash, fever, delirium; and, in three cases, convulsions).
In these eight children the average interval from exposure
to first behavioural symptoms was 6·3 days (range 1–14).
Parents  were  less  clear  about  the  timing  of  onset  of
abdominal  symptoms  because  children  were  not  toilet
Child Age (years) Sex Abnormal laboratory tests Endoscopic findings Histological findings
1 4 M Hb 10·8, PCV 0·36, WBC 16·6 Ileum not intubated; aphthoid ulcer  Acute caecal cryptitis and chronic non-specific
(neutrophilia), lymphocytes 1·8, ALP 166 in rectum colitis
2 9·5 M Hb 10·7 LNH of T ileum and colon; patchy loss of Acute and chronic non-specific colitis: reactive ileal
vascular pattern; caecal aphthoid ulcer lymphoid hyperplasia
3 7 M MCV 74, platelets 474, eosinophils 2·68, LNH of T ileum Acute and chronic non-specific colitis: reactive ileal
IgE 114, IgG1 8·4 and colonic lymphoid hyperplasia
4 10 M IgE 69, IgG1 8·25, IgG4 1·006, ALP 474, AST 50 LNH of T ileum; loss of vascular pattern in Chronic non-specific colitis: reactive ileal and colonic
rectum lymphoid hyperplasia
5 8 M LNH of T lieum; proctitis with loss of Chronic non-specific colitis: reactive ileal lymphoid
vascular pattern hyperplasia
6 5 M Platelets 480, ALP 207 LNH of T ileum; loss of colonic vascular Acute and chronic non-specific colitis: reactive ileal
pattern lymphoid hyperplasia
7 3 M Hb 9·4, WBC 17·2 (neutrophilia), ESR 16, IgA 0·7 LNH of T ileum Normal
8 3·5 F IgA 0·5, IgG 7 Prominent ileal lymph nodes Acute and chronic non-specific colitis: reactive ileal
lymphoid hyperplasia
9 6 M LNH of T ileum; patchy erythema at Chronic non-specific colitis: reactive ileal and colonic
hepatic flexure lymphoid hyperplasia
10 4 M IgG1 9·0 LNH of T ileum and colon Chronic non-specific colitis: reactive ileal lymphoid
hyperplasia
11 6 M Hb 11·2, IgA 0·26, IgM 3·4 LNH of T ileum Chronic non-specific colitis
12 7 M IgA 0·7 LNH on barium follow-through;  Chronic non-specific colitis: reactive colonic 
colonoscopy normal; ileum not intubated lymphoid hyperplasia
LNH=lymphoid nodular hyperplasia; T ileum=terminal ileum. Normal ranges and units: Hb=haemoglobin 11·5–14·5 g/dL; PCV=packed cell volume 0·37–0·45; MCV=mean cell
volume 76–100 pg/dL; platelets 140–400 10
9/L; WBC=white cell count 5·0–15·5 10
9/L; lymphocytes 2·2–8·6 10
9/L; eosinophils 0–0·4 10
9/L; ESR=erythrocyte sedimentation rate
0–15 mm/h; IgG 8–18 g/L; IgG1 3·53–7·25 g/L; IgG4 0·1–0·99 g/L; IgA 0·9–4·5 g/L; IgM 0·6–2·8 g/L; IgE 0–62 g/L; ALP=alkaline phosphatase 35–130 U/L; AST=aspartate
transaminase 5–40 U/L.
Table 1: Clinical details and laboratory, endoscopic, and histological findings
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Figure 1: Urinary methylmalonic-acid excretion in patients and
controls
p=Significance of mean excretion in patients compared with controls.
trained at the time or because behavioural features made
children unable to communicate symptoms.
One  child  (child  four)  had  received  monovalent
measles  vaccine  at  15  months,  after  which  his
development  slowed  (confirmed  by  professional
assessors). No association was made with the vaccine at
this  time.  He  received  a  dose  of  measles,  mumps,  and
rubella vaccine at age 4·5 years, the day after which his
mother described a striking deterioration in his behaviour
that  she  did  link  with  the  immunisation.  Child  nine
received  measles,  mumps,  and  rubella  vaccine  at  16
months. At 18 months he developed recurrent antibiotic-
resistant otitis media and the first behavioural symptoms,
including disinterest in his sibling and lack of play.
Table  2  summarises  the  neuropsychiatric  diagnoses;
the  apparent  precipitating  events;  onset  of  behavioural
features; and age of onset of both behaviour and bowel
symptoms.
Laboratory tests
All children were antiendomyseal-antibody negative and
common enteric pathogens were not identified by culture,
microscopy,  or  serology.  Urinary  methylmalonic-acid
excretion was significantly raised in all eight children who
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were  tested,  compared  with  age-matched  controls
(p=0·003; figure 1). Abnormal laboratory tests are shown
in table 1.
Endoscopic findings
The caecum was seen in all cases, and the ileum in all but
two  cases.  Endoscopic  findings  are  shown  in  table  1.
Macroscopic  colonic  appearances  were  reported  as
normal in four children. The remaining eight had colonic
and  rectal  mucosal  abnormalities  including  granularity,
loss  of  vascular  pattern,  patchy  erythema,  lymphoid
nodular  hyperplasia,  and  in  two  cases,  aphthoid
ulceration. Four cases showed the “red halo” sign around
swollen  caecal  lymphoid  follicles,  an  early  endoscopic
feature  of  Crohn’s  disease.
3 The  most  striking  and
consistent  feature  was  lymphoid  nodular  hyperplasia  of
the  terminal  ileum  which  was  seen  in  nine  children
(figure 2), and identified by barium follow-through in one
other  child  in  whom  the  ileum  was  not  reached  at
endoscopy.  The  normal  endoscopic  appearance  of  the
terminal ileum (figure 2) was seen in the seven children
whose images were available for comparison.
Histological findings
Histological findings are summarised in table 1. 
Terminal ileum A reactive lymphoid follicular hyperplasia
was present in the ileal biopsies of seven children. In each
case, more than three expanded and confluent lymphoid
follicles  with  reactive  germinal  centres  were  identified
within  the  tissue  section  (figure  3).  There  was  no
neutrophil infiltrate and granulomas were not present.
Colon The lamina propria was infiltrated by mononuclear
cells  (mainly  lymphocytes  and  macrophages)  in  the
colonic-biopsy  samples.  The  extent  ranged  in  severity
from  scattered  focal  collections  of  cells  beneath  the
surface epithelium (five cases) to diffuse infiltration of the
mucosa  (six  cases).  There  was  no  increase  in
intraepithelial lymphocytes, except in one case, in which
numerous  lymphocytes  had  infiltrated  the  surface
epithelium  in  the  proximal  colonic  biopsies.  Lymphoid
follicles  in  the  vicinity  of  mononuclear-cell  infiltrates
showed enlarged germinal centres with reactive changes
that included an excess of tingible body macrophages.
There was no clear correlation between the endoscopic
appearances  and  the  histological  findings;  chronic
inflammatory  changes  were  apparent  histologically  in
endoscopically  normal  areas  of  the  colon.  In  five  cases
there was focal acute inflammation with infiltration of the
lamina  propria  by  neutrophils;  in  three  of  these,
neutrophils  infiltrated  the  caecal  (figure  3)  and  rectal-
crypt  epithelium.  There  were  no  crypt  abscesses.
Occasional  bifid  crypts  were  noted  but  overall  crypt
architecture  was  normal.  There  was  no  goblet-cell
depletion but occasional collections of eosinophils were
seen  in  the  mucosa.  There  were  no  granulomata.
Parasites  and  organisms  were  not  seen.  None  of  the
changes described above were seen in any of the normal
biopsy specimens.
Discussion
We  describe  a  pattern  of  colitis  and  ileal-lymphoid-
nodular  hyperplasia  in  children  with  developmental
disorders.  Intestinal  and  behavioural  pathologies  may
have occurred together by chance, reflecting a selection
bias in a self-referred group; however, the uniformity of
the  intestinal  pathological  changes  and  the  fact  that
previous  studies  have  found  intestinal  dysfunction  in
children  with  autistic-spectrum  disorders,  suggests  that
the  connection  is  real  and  reflects  a  unique  disease
process.
Asperger first recorded the link between coeliac disease
and  behavioural  psychoses.
4 Walker-Smith  and
colleagues
5 detected  low  concentrations  of  alpha-1
antitrypsin  in  children  with  typical  autism,  and
D’Eufemia and colleagues
6 identified abnormal intestinal
permeability, a feature of small intestinal enteropathy, in
43%  of  a  group  of  autistic  children  with  no
gastrointestinal symptoms, but not in matched controls.
These studies, together with our own, including evidence
of anaemia and IgA deficiency in some children, would
support  the  hypothesis  that  the  consequences  of  an
inflamed  or  dysfunctional  intestine  may  play  a  part  in
behavioural changes in some children.
Child Behavioural Exposure identified Interval from exposure to Features associated with  Age at onset of first symptom
diagnosis by parents or doctor first behavioural symptom exposure
Behaviour Bowel
1 Autism MMR 1 week Fever/delirium 12 months Not known
2 Autism MMR 2 weeks Self injury 13 months 20 months
3 Autism MMR 48 h Rash and fever 14 months Not known
4 Autism? MMR Measles vaccine at 15 months Repetitive behaviour, 4·5 years 18 months
Disintegrative followed by slowing in development. self injury,
disorder? Dramatic deterioration in behaviour loss of self-help
immediately after MMR at 4·5 years
5 Autism None—MMR at 16 Self-injurious behaviour started at 4 years
months 18 months
6 Autism MMR 1 week Rash & convulsion; gaze 15 months 18 months
avoidance & self injury
7 Autism MMR 24 h Convulsion, gaze avoidance 21 months 2 years
8 Post-vaccinial MMR  2 weeks Fever, convulsion, rash & 19 months 19 months
encephalitis? diarrhoea
9 Autistic spectrum Recurrent otitis media 1 week (MMR 2 months previously) Disinterest; lack of play 18 months 2·5 years
disorder
10 Post-viral Measles (previously 24 h Fever, rash & vomiting 15 months Not known
encephalitis? vaccinated with MMR)
11 Autism MMR 1 week Recurrent “viral pneumonia” 15 months Not known
for 8 weeks following MMR
12 Autism None—MMR at 15 months Loss of speech development and Not known
deterioration in language skills noted
at 16 months
MMR=measles, mumps, and rubella vaccine.
Table 2: Neuropsychiatric diagnosis
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Figure 2: Endoscopic view of terminal ilium in child three and
in a child with endoscopically and histologically normal ileum
and colon
Greatly enlarged lymphoid nodule in right-hand field of view. A and
B=child three; C=normal ileum. Remainder of mucosal surface of`
terminal ileum is a carpet of enlarged lymphoid nodules.
Figure 3: Biopsy sample from terminal ileum (top) and from
colon (bottom)
A=child three; lymphoid hyperplasia with extensive, confluent lymphoid
nodules. B=child three; dense infiltration of the lamina propria crypt
epithelium by neutrophils and mononuclear cells. Stained with
haematoxylin and eosin.
The “opioid excess” theory of autism, put forward first
by  Panksepp  and  colleagues
7 and  later  by  Reichelt  and
colleagues
8 and  Shattock  and  colleagues
9 proposes  that
autistic disorders result from the incomplete breakdown
and  excessive  absorption  of  gut-derived  peptides  from
foods, including barley, rye, oats, and caesin from milk
and  dairy  produce.  These  peptides  may  exert  central-
opioid  effects,  directly  or  through  the  formation  of
ligands with peptidase enzymes required for breakdown
of  endogenous  central-nervous-system  opioids,
9 leading
to  disruption  of  normal  neuroregulation  and  brain
development by endogenous encephalins and endorphins.
One aspect of impaired intestinal function that could
permit  increased  permeability  to  exogenous  peptides  is
deficiency  of  the  phenyl-sulphur-transferase  systems,  as
described  by  Waring.
10 The  normally  sulphated
glycoprotein matrix of the gut wall acts to regulate cell
and molecular trafficking.
11 Disruption of this matrix and
increased  intestinal  permeability,  both  features  of
inflammatory bowel disease,
17 may cause both intestinal
and neuropsychiatric dysfunction. Impaired enterohepatic
sulphation and consequent detoxification of compounds
such  as  the  phenolic  amines  (dopamine,  tyramine,  and
serotonin)
12 may  also  contribute.  Both  the  presence  of
intestinal  inflammation  and  absence  of  detectable
neurological  abnormality  in  our  children  are  consistent
with  an  exogenous  influence  upon  cerebral  function.
Lucarelli’s observation that after removal of a provocative
enteric  antigen  children  achieved  symptomatic
behavioural  improvement,  suggests  a  reversible  element
in this condition.
13
Despite  consistent  gastrointestinal  findings,
behavioural  changes  in  these  children  were  more
heterogeneous.  In  some  cases  the  onset  and  course  of
behavioural  regression  was  precipitous,  with  children
losing  all  communication  skills  over  a  few  weeks  to
months. This regression is consistent with a disintegrative
psychosis (Heller’s disease), which typically occurs when
normally  developing  children  show  striking  behaviour
changes  and  developmental  regression,  commonly  in
association with some loss of coordination and bowel or
bladder  function.
14 Disintegrative  psychosis  is  typically
described as occurring in children after at least 2–3 years
of apparently normal development.
Disintegrative  psychosis  is  recognised  as  a  sequel  to
measles encephalitis, although in most cases no cause is
ever identified.
14 Viral encephalitis can give rise to autistic
disorders,  particularly  when  it  occurs  early  in  life.
15
Rubella virus is associated with autism and the combined
measles,  mumps,  and  rubella  vaccine  (rather  than
monovalent  measles  vaccine)  has  also  been  implicated.
Fudenberg
16 noted that for 15 of 20 autistic children, the
first symptoms developed within a week of vaccination.
Gupta
17 commented on the striking association between
measles, mumps, and rubella vaccination and the onset of
behavioural  symptoms  in  all  the  children  that  he  had
investigated  for  regressive  autism.  Measles  virus
18,19 and
measles vaccination
20 have both been implicated as risk
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factors  for  Crohn’s  disease  and  persistent  measles
vaccine-strain virus infection has been found in children
with autoimmune hepatitis.
21
We  did  not  prove  an  association  between  measles,
mumps, and rubella vaccine and the syndrome described.
Virological studies are underway that may help to resolve
this issue.
If there is a causal link between measles, mumps, and
rubella  vaccine  and  this  syndrome,  a  rising  incidence
might be anticipated after the introduction of this vaccine
in the UK in 1988. Published evidence is inadequate to
show whether there is a change in incidence
22 or a link
with  measles,  mumps,  and  rubella  vaccine.
23 A  genetic
predisposition to autistic-spectrum disorders is suggested
by over-representation in boys and a greater concordance
rate  in  monozygotic  than  in  dizygotic  twins.
15 In  the
context of susceptibility to infection, a genetic association
with autism, linked to a null allele of the complement (C)
4B gene  located  in  the  class  III  region  of  the  major-
histocompatibility complex, has been recorded by Warren
and colleagues.
24 C4B-gene products are crucial for the
activation  of  the  complement  pathway  and  protection
against infection: individuals inheriting one or two C4B
null alleles may not handle certain viruses appropriately,
possibly including attenuated strains.
Urinary methylmalonic-acid concentrations were raised
in  most  of  the  children,  a  finding  indicative  of  a
functional vitamin B12 deficiency. Although vitamin B12
concentrations  were  normal,  serum  B12  is  not  a  good
measure  of  functional  B12  status.
25 Urinary
methylmalonic-acid  excretion  is  increased  in  disorders
such as Crohn’s disease, in which cobalamin excreted in
bile  is  not  reabsorbed.  A  similar  problem  may  have
occurred  in  the  children  in  our  study.  Vitamin  B12  is
essential  for  myelinogenesis  in  the  developing  central
nervous  system,  a  process  that  is  not  complete  until
around  the  age  of  10  years.  B12  deficiency  may,
therefore, be a contributory factor in the developmental
regression.
26
We have identified a chronic enterocolitis in children
that may be related to neuropsychiatric dysfunction. In
most  cases,  onset  of  symptoms  was  after  measles,
mumps, and rubella immunisation. Further investigations
are  needed  to  examine  this  syndrome  and  its  possible
relation to this vaccine.
Addendum:
Up  to  Jan  28,  a  further  40  patients  have  been  assessed;  39  with  the
syndrome.
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